TrialMax App vs IQVIA Scribe

TrialMax from Signant Health is used for collecting data from patients and their caregivers in clinical trials of new medicines. TrialMax gives patients access to study specific questionnaires making it easy for the patients to fill them in wherever they go. Patients who participate in a particular clinical study get access to TrialMax for the duration of the study. The app is activated with an activation code supplied by the care personnel conducting the clinical study. TrialMax, with its easy to use interface, will help make your participation in a clinical trial as easy as possible. The reminders will help you follow the study protocol and be compliant. TrialMax ensures your privacy and anonymity in a clinical trial. The app complies with international regulations and laws for patient privacy.

IQVIA Scribe is an online/offline application used to capture data directly from patients enrolled in clinical trials. Patients enrolled in a study using Scribe will receive an enrollment notification via email or text with a link to download the application and instructions used to enroll in the study. Relevant questionnaires will be available for completion throughout the duration of the study ++++Scribe amplifies the patient's voice in clinical research by allowing Clinical Outcomes Assessments to be used in more trials. Whether deploying to smartphones, tablets or the web, our Sculptor visual build and deployment tools help automate the eCOA process, giving absolute transparency and greater control to sponsors and CRO’s.